Open access
2026
Serum neurofilament light chain as a biomarker for monitoring the therapeutic response of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis
Initiation of DMTs in RRMS patients was associated with a significant decrease in sNfL levels, suggesting reduced neuroaxonal damage following treatment introduction, and monitoring sNfL may represent a useful non-invasive biomarker of biological treatment response in RRMS patients.
M. Vasić, E. Dinčić
· Vojnosanitetski Pregled · 0 citations